CBD Spray is a cannabidiol supplement in the form of an oral spray to be applied under the tongue. It helps to relieve pain, reduce inflammation, promote relaxation and protect neural function.
The CBD in this high-quality supplement crosses the mucous membranes almost instantly, resulting in rapid, optimal absorption by the body. CBD Spray also provides a significantly higher CBD intake than standard supplements, and boasts an exemplary safety profile.
What exactly is CBD?
Cannabidiol, or CBD as it’s more commonly known, is a phytocannabinoid found in hemp (Cannabis sativa). Phytocannabinoids are metabolites produced by the plant to help it survive and withstand external attack.
Humans are able to capture some of these compounds, including cannabidiol, by means of cannabinoid receptors. In fact, the human body has an endocannabinoid system (ECS), a communication network which supports many physiological processes.
Unlike tetrahydrocannabinol (THC), another hemp phytocannabinoid, CBD has no narcotic properties.
The benefits of CBD Spray
The product CBD Spray provides an excellent intake of cannabidiol (CBD), with each spray delivering 10mg of CBD.
The interaction between CBD and two key receptors of the endocannabinoid system (CB1 and CB2) produces multiple benefits for health, as has been observed by numerous scientific studies in recent years. We now know that CBD has the following properties:
- analgesic (pain-relieving). Several studies have demonstrated its efficacy for chronic pain in particular (1-3) ;
- anti-inflammatory. CBD helps to reduce levels of pro-inflammatory cytokines (4-6);
- anti-migraine. Research has shown an association between a reduction in migraine frequency and intensity and consumption of phytocannabinoids (7-8);
- relaxing, anxiolytic and sleep-inducing. CBD affects regions of the brain involved in the neurobiology of several cerebral problems such as persistent stress and anxiety (9-10);
- antipsychotic and neuroprotective. CBD plays a role in increasing adenosine levels in the brain, which is associated with neuroprotection (11-12);
- antioxidant, immunomodulatory, anti-angiogenic, cardioprotective(13-16), etc.
Why choose a CBD supplement in spray form?
The sublingual spray ensures faster absorption of the CBD than is the case with standard capsules. When administered via an oral spray, the active ingredients in cannabidiol cross the buccolingual mucous membranes to enter the bloodstream directly, unaffected by the digestive process. This spray delivery method thus offers optimal efficacy, with effects normally starting to be felt around ten minutes after absorption.
The spray format is also very convenient for everyday use: you don’t need a glass of water to take it. CBD Spray can be used at any time of day, even when you’re outdoors.
And unlike capsules, this oral CBD spray has a refreshing mint taste.
How to use your oral CBD spray
To take CBD Spray, simply shake the bottle, remove the cap and spray once under your tongue. Try to keep the substance in your mouth for a minute before swallowing.
Depending on the effects obtained, you can re-use the spray several times during the day or night.
Does CBD Spray have any side-effects?
CBD Spray has an excellent safety profile :
- firstly, the cannabis used contains no THC and thus induces no psychoactive effect in the consumer;
- in addition, the CBD does not produce any adverse side-effects – there are no changes to the body’s heart rate, blood pressure or temperature;
- it does not lead to cannabinoid addiction;
- after a few hours, the CBD in CBD Spray is naturally excreted in urine, in a metabolised form.
Daily dose: 1 spray
Number of sprays per bottle: 80 |
Amount per dose |
CBD |
10 mg |
Other ingredients: water, glycerine, peppermint flavour, soy lecithin, sodium benzoate, citric acid. This supplement contains no psychoactive substance. |
Adults. Use the spray once, or several times, a day. Each spray contains 10mg of CBD.
This supplement contains no psychoactive substance.
- Russo EB. Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag. 2008;4(1):245-259. doi:10.2147/tcrm.s1928
- Xiong W, Cui T, Cheng K, et al. Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. J Exp Med. 2012;209(6):1121-1134. doi:10.1084/jem.20120242
- Manzanares J, Julian M, Carrascosa A. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol. 2006;4(3):239-257. doi:10.2174/157015906778019527
- Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants (Basel). 2019;9(1):21. Published 2019 Dec 25. doi:10.3390/antiox9010021
- Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008 Jan;153(2):199-215. doi: 10.1038/sj.bjp.0707442. Epub 2007 Sep 10. PMID: 17828291; PMCID: PMC2219532.
- Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009;1(7):1333-1349. doi:10.4155/fmc.09.93
- Rhyne DN, Anderson SL, Gedde M, Borgelt LM. Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population. Pharmacotherapy. 2016 May;36(5):505-10. doi: 10.1002/phar.1673. Epub 2016 Jan 9. PMID: 26749285.
- Lochte BC, Beletsky A, Samuel NK, Grant I. The Use of Cannabis for Headache Disorders. Cannabis Cannabinoid Res. 2017;2(1):61-71. Published 2017 Apr 1. doi:10.1089/can.2016.0033
- Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 2015;12(4):825-836. doi:10.1007/s13311-015-0387-1
- Kuhathasan N, Dufort A, MacKillop J, Gottschalk R, Minuzzi L, Frey BN. The use of cannabinoids for sleep: A critical review on clinical trials. Exp Clin Psychopharmacol. 2019 Aug;27(4):383-401. doi: 10.1037/pha0000285. Epub 2019 May 23. PMID: 31120284.
- Maroon J, Bost J. Review of the neurological benefits of phytocannabinoids. Surg Neurol Int. 2018;9:91. Published 2018 Apr 26. doi:10.4103/sni.sni_45_18
- Castillo A, Tolón MR, Fernández-Ruiz J, Romero J, Martinez-Orgado J. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. Neurobiol Dis. 2010 Feb;37(2):434-40. doi: 10.1016/j.nbd.2009.10.023. Epub 2009 Nov 6. PMID: 19900555.
- Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants (Basel). 2019;9(1):21. Published 2019 Dec 25. doi:10.3390/antiox9010021
- Kaplan BL, Springs AE, Kaminski NE. The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT). Biochem Pharmacol. 2008;76(6):726-737. doi:10.1016/j.bcp.2008.06.022
- Dariš B, Tancer Verboten M, Knez Ž, Ferk P. Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosn J Basic Med Sci. 2019;19(1):14-23. Published 2019 Feb 12. doi:10.17305/bjbms.2018.3532
- Kicman A, Toczek M. The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease. Int J Mol Sci. 2020 Sep 14;21(18):6740. doi: 10.3390/ijms21186740. PMID: 32937917; PMCID: PMC7554803.
- Sprouse-Blum AS, Smith G, Sugai D, Parsa FD. Understanding endorphins and their importance in pain management. Hawaii Med J. 2010;69(3):70-71.
- Galland L. Diet and inflammation. Nutr Clin Pract. 2010 Dec;25(6):634-40. doi: 10.1177/0884533610385703. PMID: 21139128.
- Na W, Yu TY, Sohn C. Development of a food-based index of dietary inflammatory potential for Koreans and its relationship with metabolic syndrome. Nutr Res Pract. 2019;13(2):150-158. doi:10.4162/nrp.2019.13.2.150
- Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009 Jun;14(2):141-53. Erratum in: Altern Med Rev. 2009 Sep;14(3):277. PMID: 19594223.
- EFSA Register of Questions - Europa EU
- Lin Y, Shi R, Wang X, Shen HM. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets. 2008;8(7):634-646. doi:10.2174/156800908786241050
- Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, Imran A, Orhan IE, Rizwan M, Atif M, Gondal TA, Mubarak MS. Luteolin, a flavonoid, as an anticancer agent: A review. Biomed Pharmacother. 2019 Apr;112:108612. doi: 10.1016/j.biopha.2019.108612. Epub 2019 Feb 21. Erratum in: Biomed Pharmacother. 2019 Aug;116:109084. PMID: 30798142.
- Aziz N, Kim MY, Cho JY. Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies. J Ethnopharmacol. 2018 Oct 28;225:342-358. doi: 10.1016/j.jep.2018.05.019. Epub 2018 May 22. PMID: 29801717.